Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.

J Forensic Sci

Department of Pathology and Laboratory Medicine, Foothills Medical Center, Cumming School of Medicine, University of Calgary, McCaig Tower 7542, 1403 29 Street NW, Calgary, AB, T2N 2T9, Canada.

Published: January 2019

Cannabinoid hyperemesis syndrome (CHS) is one of the more clinically challenging effects of cannabis consumption. It is characterized by cyclic attacks of nausea and vomiting in chronic cannabinoid users and learned behavior of compulsive hot bathing. The deaths of a 27-year-old female, a 27-year-old male, and a 31-year-old male with a history of CHS are reported. The decedents had a history of cyclical nausea and vomiting, chronic cannabinoid use and negative laboratory, radiological and endoscopic findings. All presented to the emergency department with nausea and vomiting in the days preceding death and were treated symptomatically. Toxicological analysis revealed tetrahydrocannabinol in postmortem blood. The cause of death of two of the three cases was attributed to CHS. CHS was appreciated in the third case but was not the cause of death. These three cases demonstrate the importance of recognizing CHS as a potential cause or contributing factor to death in cannabinoid user.

Download full-text PDF

Source
http://dx.doi.org/10.1111/1556-4029.13819DOI Listing

Publication Analysis

Top Keywords

nausea vomiting
12
cannabinoid hyperemesis
8
hyperemesis syndrome
8
vomiting chronic
8
chronic cannabinoid
8
death three
8
three cases
8
cannabinoid
5
chs
5
syndrome reports
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!